Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial.
Prophylactic Antibiotic Regimens in Tumor Surgery , ; Ghert, M; Schneider, P; Guyatt, G; Thabane, L; Vélez, R; O'Shea, T; Randall, RL; Turcotte, R; Wilson, D; et al.
JAMA Oncology.
2022;
8:345-353.
Prophylactic Antibiotic Regimens In Tumor Surgery (PARITY): a multi-center randomized controlled study comparing alternative antibiotic regimens in patients undergoing tumor resections with endoprosthetic replacements-a statistical analysis plan.
Schneider, P; Heels-Ansdell, D; Thabane, L; Ghert, M; Bhandari, M; Deheshi, B; Guyatt, G; Holt, G; O’Shea, T; Randall, RL; et al.
Trials.
2021;
22.
Novel ARHGAP23-FER fusion in a metastatic spindle cell-predominant neoplasm with a myofibroblastic phenotype and a sustained metabolic response to lorlatinib.
Sadaf, A; Szabo, S; Ferguson, K; Sorger, JI; Sumegi, J; Bridge, JA; Pressey, JG.
Cancer.
2021;
127:4124-4130.
Implant Survival and Clinical Outcomes of Total Hip Arthroplasty in Adolescent and Young Adult Patients.
Zeitlinger, L; Gemayel, A; Whitlock, P; Sorger, J.
2021;
05:062-069.
A large intermuscular shoulder lipoma causing pain and weakness in an 87-year-old patient: a case report.
Hasan, SS; O'Loughlin, JP; Sorger, JI.
JSES International.
2021;
5:154-157.
Solitary myofibroma preceding the development of multicentric myofibromatosis: A report of two cases with surveillance recommendations.
Todd, K; Kim, HK; Szabo, S; Johnson, S; Pressey, J; Nagarajan, R; Sorger, J; Dasgupta, R; Turpin, B.
Pediatric Blood and Cancer.
2020;
67.
Orthopedic issues in vascular anomalies.
Spencer, SA; Sorger, JI.
Seminars in Pediatric Surgery.
2020;
29.
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.
Weiss, AR; Chen, Y; Scharschmidt, TJ; Chi, Y; Tian, J; Black, JO; Davis, JL; Fanburg-Smith, JC; Zambrano, E; Anderson, J; et al.
The Lancet Oncology.
2020;
21:1110-1122.
A phase II study of larotrectinib for children with newly diagnosed solid tumors and relapsed acute leukemias harboring TRK fusions: Children’s Oncology Group study ADVL1823.
Laetsch, TW; Ludwig, K; Barkauskas, DA; DuBois, SG; Ronan, J; Rudzinski, ER; Memken, A; Sorger, J; Reid, JM; Bhatla, T; et al.
Journal of Clinical Oncology.
2020;
38:tps10560-tps10560.
Preoperative chemoradiation +/- pazopanib in non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): A report from Children's Oncology Group (COG) and NRG Oncology.
Weiss, AR; Chi, Y; Chen, Y; Choy, E; Davis, JL; Fanburg-Smith, J; Hawkins, DS; Kayton, M; Million, L; Okuno, SH; et al.
Journal of Clinical Oncology.
2019;
37:11002-11002.